Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2021-02-04 Regulatory Filings
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2021-02-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text is very short (811 characters) and mainly contains address and listing information for stock exchanges (National Stock Exchange of India, BSE Limited, Luxembourg Stock Exchange, London Stock Exchange). There is no substantive financial data, no report content, no management discussion, no voting results, no legal proceedings, or other detailed information. It appears to be a brief announcement or notice related to listing or exchange information. Given the brevity and nature of the content, it does not qualify as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-02-02 English
Updates
Regulatory Filings Classification · 95% confidence The document is very short (1017 characters) and appears to be a formal letter or notice addressed to stock exchanges (NSE, BSE, Luxembourg Stock Exchange, London Stock Exchange) with company identification details and addresses. There is no substantive financial data, no detailed report content, no mention of financial results, management discussion, or audit information. The text does not contain any financial statements or detailed disclosures. It looks like a regulatory or listing-related communication, possibly a formal notification or announcement to exchanges. Given the brevity and nature, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document text is extremely short (561 characters) and contains only header information related to stock exchanges and listing departments, with no substantive content or financial data. There is no indication of a full report, financial statements, or detailed disclosures. It appears to be a brief announcement or notice related to stock exchange listings without any report attached or detailed information. According to the rules, such short documents that do not contain actual report content and do not fit other categories should be classified as Regulatory Filings (RNS).
2021-01-03 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report titled 'Consolidated Scrutinizer's Report' related to the voting results of the 27th Annual General Meeting (AGM) of Orchid Pharma Limited. It references the voting process, e-voting, and the resolutions passed at the AGM. The document includes procedural details about the voting, dates, and compliance with relevant company law and SEBI regulations. It does not contain financial statements or management discussion but focuses on the disclosure of voting results and the scrutinizer's findings. Therefore, this document fits the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length and content confirm it is not a brief announcement but a full report of voting results, consistent with DVA filings.
2021-01-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (748 characters) and contains only listing department addresses and stock exchange information for National Stock Exchange of India Ltd, BSE Limited, Luxembourg Stock Exchange, and London Stock Exchange. There is no substantive financial data, no report content, no management discussion, no voting results, no legal proceedings, or any other detailed information. It appears to be a brief regulatory announcement or listing information rather than a full report or detailed filing. Given the brevity and nature of the content, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-01-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.